Seamus Mulligan, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,864,954 shares at $49.56 ($99.1M) on 2012-03-09, disclosed to the SEC on 2012-03-13.
Open-market sale of $99.1M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 864,954 | $0 | 0.0% |
| 2 | $49.56 | 2,000,000 | $99.1M | 100.0% |
| Total | $34.60 avg | 2,864,954 | $99.1M | 100% |
| Filing → |
| JAZZ | BUY | 2018-11-19 | $14.2M | — | Filing → |
| JAZZ | SELL | 2016-08-26 | $6.0M | — | Filing → |
| JAZZ | SELL | 2016-05-26 | $8.2M | — | Filing → |